Active Ratio Test (ART) as a Novel Diagnostic for Ovarian Cancer

Active Ratio Test (ART) as a Novel Diagnostic for Ovarian Cancer

Background: Despite substantial effort, there remains a lack of biomarker-based, clinically relevant testing for the accurate, non-invasive diagnostic or prognostic profiling of epithelial ovarian cancers (EOC). Our previous work demonstrated that whilst the inflammatory marker C-X-C motif chemokine...

Full description

Bibliographic Details
Main Authors: Sung-Woog Kang, Adam Rainczuk, Martin K. Oehler, Thomas W. Jobling, Magdalena Plebanski, Andrew N. Stephens
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Diagnostics
Subjects:
ovarian cancer
CXCL10
Active Ratio Test
biomarkers
early detection
ELISA
Online Access:https://www.mdpi.com/2075-4418/11/6/1048

Internet

https://www.mdpi.com/2075-4418/11/6/1048

Similar Items